Silo Pharma, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Silo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q1 2023.
- Silo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $906K, a 50.3% increase year-over-year.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)